MedPage Today on MSN

In-Utero Repair of Severe Spina Bifida With Stem Cells Shows Promise

A first in-human, phase I trial examined feasibility as well as safety ...
Medscape

First-in-Human Trial Supports Safety, Feasibility of Stem Cell Therapy in Prenatal Spina Bifida Repair

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...
Medscape

Prenatal Myelomeningocele Repair Improves Outcomes: The MOMS Trial

February 9, 2011 — Repairing a myelomeningocele in utero, rather than after birth, reduces the risk for fetal or neonatal death and the need for shunting by age 1 and substantially improves neurologic ...
News Medical

Prenatal repair of myelomeningocele reduces need for CSF shunt within 12 months of life, shows MOMS data

Management of Myelomeningocele Study (MOMS) investigators analyzed updated data on the effects of prenatal myelomeningocele closure on the need for placement of a cerebrospinal fluid (CSF) shunt ...